Andexanet alfa is associated with lower in-hospital mortality compared to 4-factor prothrombin complex concentrate in patients with factor Xa inhibitor-related major bleeding

June 26th, 2023 | Paul P. Dobesh, Pharm.D.; University of Nebraska Medical Center, College of Pharmacy; Omaha, NE, U.S.

Platelet-derived integrin and tetraspanin-enriched tethers (PITTs) orchestrate neutrophil recruitment and drive pulmonary thrombo-inflammation

June 26, 2023 | Denise Johnson, M.Sc.; Institute of Experimental Biomedicine I; University Hospital Würzburg; Würzburg, Germany